David Gozal, MD, is an international expert in the field of sleep medicine. He is known as a pioneer in the study of childhood sleep problems and the relationships between sleep disorders and neurobehavioral, cardiovascular and metabolic disease.
His research has been funded by multiple National Institutes of Health grants and focuses on translational approaches to pediatric sleep disorders, such as childhood obstructive sleep apnea (OSA) and sudden infant death syndrome. An accomplished author and speaker, he has published more than 600 peer-reviewed articles, more than 150 book chapters and reviews, edited three books and has extensively lectured at scientific meetings around the world.
Education & Training
- UCSF Benioff Children's Hospital
MBA, Georgetown University in Washington, D.C.
Commercial Relationships and Collaborations
This faculty member or a member of his or her immediate family has a working relationship, such as providing consulting, research, or educational services, with the companies listed below. These relationships have been reported to the University of Missouri and, if appropriate, plans have been established to address potential conflicts. The following relationships were reported as of July 2020.
- Serenium Inc
MU Health Care participates with most major managed care organizations. To find out whether MU Health Care is a participating provider in your insurance plan or network, or for information on co-payments and deductibles, please contact your insurance carrier directly.
In the News
400 N Keene St
Columbia, MO 65201
David Gozal, MD, MBA, PhD (Hon), is an International sleep expert Dr. Gozal works to understand the health effects of sleep disorders in children.
A pediatric pulmonologist and sleep medicine specialist, Gozal studies the developmental neurobiology of respiratory control. He focuses on pediatric sleep disorders and their relationship to neurobehavioral, cardiovascular and metabolic diseases.
Gozal has conducted extensive research on sleep apnea, a frequent breathing disorder during sleep. He has studied the effectiveness of diagnostic technologies, including pioneering work in creating a biomarker for sleep apnea as well as applying machine learning and artificial intelligence. He has also investigated how nonsurgical treatments might reduce symptoms and improve cognition and behavior among children with sleep apnea. Additionally, he has addressed health effects of sleep apnea, examined the impact of sleep-disordered breathing on school performance, and identified mechanisms and approaches that should enable personalized treatment in the near future.
Gozal has lectured throughout the world on sleep disorders in pediatric patients. He has written more than 630 articles as well as 150 book chapters and reviews on the subject. He has served as president of the American Thoracic Society and has been the recipient of multiple distinguished national and international awards. His research has been continuously funded by the National Institutes of Health.
Dr. David Gozal is the Mary M. and Harry L. Smith Endowed Chair of Child Health at the MU School of Medicine.
- Sleep apnea
- Sleep fragmentation and deprivation
- Intermittent hypoxia
- Endothelial function
- Adipose tissue
- Cognition and behavior
- Gut microbiome
- Tumor biology
- Machine learning
Areas of Expertise
- Sleep disorders
- Pediatric respiratory diseases
- Cardiorespiratory physiology